CoChat

Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis

Open access
Kim, Chan Hee, Chon, Seung Joo, Lee, Seon Heui · 2020 · Scientific Reports
Cited by 73

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Polycystic ovary syndrome (PCOS) is a common disease that has an effect on approximately 10% of women of childbearing age. Although there is evidence regarding the role of lifestyle factors in the development of PCOS, the exact etiology remains unclear. Additionally, metformin is used in the treatment of PCOS but its role remains unclear. We compared the effects of lifestyle modification (LSM) + metformin and metformin alone on PCOS. We performed a systematic review by searching electronic databases for publications until December 2019. The primary endpoints were clinical outcomes, such as menstrual cycles and pregnancy rates, and the secondary endpoints were anthropometric, metabolic, and androgenic parameters. The meta-analysis revealed that there was no significant difference in the improvements in the menstrual cycles between LSM and metformin alone (weighted mean difference [MD] = 1.62) and between LSM + metformin and LSM (MD = 1.20). The pregnancy rates and body mass indices were not significantly different between LSM and metformin alone (MD = 1.44 and −0.11, respectively). LSM reduced insulin resistance (MD = −0.52) and increased serum levels of sex hormone-binding globulins (MD = 8.27) compared with metformin. Therefore, we suggest recommending lifestyle modifications actively to women with PCOS if they do not have indications for metformin.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-64776-w

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Research works printed but not linked: 19

  1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility 81, 19–25, https://doi.org/10.1016/j.fertnstert.2003.10.004 (2004). · DOI · Paper page
  2. Soter, M. O. et al. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome. Cytokine 76, 227–235, https://doi.org/10.1016/j.cyto.2015.06.008 (2015). · DOI
  3. Dunaif, A. Perspectives in polycystic ovary syndrome: from hair to eternity. The Journal of clinical endocrinology and metabolism 101, 759–768, https://doi.org/10.1210/jc.2015-3780 (2016). · DOI · Paper page
  4. Nehir Aytan, A. et al. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Gynecological endocrinology 32, 709–713, https://doi.org/10.3109/09513590.2016.1155208 (2016). · DOI
  5. Repaci, A., Gambineri, A. & Pasquali, R. The role of low-grade inflammation in the polycystic ovary syndrome. Molecular and cellular endocrinology 335, 30–41, https://doi.org/10.1016/j.mce.2010.08.002 (2011). · DOI · Paper page
  6. Carvalho, L. M. L. et al. Microparticles: inflammatory and haemostatic biomarkers in polycystic ovary syndrome. Molecular and cellular endocrinology 443, 155–162, https://doi.org/10.1016/j.mce.2017.01.017 (2017). · DOI
  7. Gaeini, A., Satarifard, S., Mohamadi, F. & Choobineh, S. The effect of 12 weeks aerobic exercise on DHEAso4, 17OH-Progestron concentrations, number of follicles and menstrual condition of women with PCOS. Hormozgan Medical Journal 18, 298–305 (2014).
  8. Stepto, N. K. et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human reproduction (Oxford, England) 28, 777–784, https://doi.org/10.1093/humrep/des463 (2013). · DOI · Paper page
  9. Karimzadeh, M. A. & Javedani, M. An assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertility and sterility 94, 216–220, https://doi.org/10.1016/j.fertnstert.2009.02.078 (2010). · DOI · Paper page
  10. Salama, A. A., Amine, E. K., Hesham, A. S. & Abd El-Fatteh, N. K. Effects of anti-inflammatory diet in the context of lifestyle modification (with or without metformin use) on metabolic, endocrine, inflammatory and reproductive profiles in overweight and obese women with polycystic ovary syndrome: Controlled clinical trial. Canadian Journal of Clinical Nutrition 6, 81–106 (2018). · doi:10.14206/canad.j.clin.nutr.2018.01.06
  11. Hoeger, K. M. et al. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertility and sterility 82, 421–429, https://doi.org/10.1016/j.fertnstert.2004.02.104 (2004). · DOI · Paper page
  12. Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U. & Pasquali, R. Obesity and the polycystic ovary syndrome. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 26, 883–896, https://doi.org/10.1038/sj.ijo.0801994 (2002). · DOI · Paper page
  13. Vanky, E. et al. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Human reproduction (Oxford, England) 19, 1734–1740, https://doi.org/10.1093/humrep/deh347 (2004). · DOI · Paper page
  14. l’Allemand, D. et al. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. Journal of clinical endocrinology and metabolism 81, 3892–3897, https://doi.org/10.1210/jcem.81.11.8923834 (1996). · doi:10.1210/jcem.81.11.8923834 · Paper page
  15. Tosi, F. et al. Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women. European journal of endocrinology 164, 197–203, https://doi.org/10.1530/eje-10-0782 (2011). · DOI · Paper page
  16. Buffington, C. K. & Kitabchi, A. E. Evidence for a defect in insulin metabolism in hyperandrogenic women with polycystic ovarian syndrome. Metabolism: clinical and experimental 43, 1367–1372 (1994). · DOI
  17. Bastard, J. P. et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. European cytokine network 17, 4–12 (2006).
  18. Ferris, W. F. & Crowther, N. J. Once fat was fat and that was that: our changing perspectives on adipose tissue. Cardiovascular journal of Africa 22, 147–154 (2011). · DOI
  19. Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (New York, N.Y.) 271, 665–668 (1996). · DOI · Paper page

Cited by

See all 73

Metadata

Authors
Kim, C. H., Chon, S. J., & Lee, S. H.
Venue
Scientific Reports
Published
2020-05-08
Volume
10
Issue
1
Pages
7802-7802
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3023256085
Cited by
73
References
17
FWCI
2.89
Type
journal article
Language
en
Open access
gold
Licence
Funders
Gachon University (GCU-2018-0313)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis. https://app.cochat.ai/papers/10.1038/s41598-020-64776-w
The paper
Kim, C. H., Chon, S. J., & Lee, S. H. (2020). Effects of lifestyle modification in polycystic ovary syndrome compared to metformin only or metformin addition: A systematic review and meta-analysis. Scientific Reports. https://doi.org/10.1038/s41598-020-64776-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.